Skip to content

The effects of transcutaneous electrical acupoint stimulation and vagus nerve electrical stimulation on cardiopulmonary function in patients undergoing laparoscopic radical resection for colorectal cancer.

The effects of transcutaneous electrical acupoint stimulation and vagus nerve electrical stimulation on cardiopulmonary function in patients undergoing laparoscopic radical resection for colorectal cancer.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025002148
Enrollment
Unknown
Registered
2025-11-08
Start date
2025-06-30
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intraoperative cardiopulmonary function protection during radical resection of colorectal cancer

Interventions

Group A:Transcutaneous Electrical Acupoint Stimulation (TEAS)
Group B:Transcutaneous Auricular Vagus Nerve Electrical Stimulation (tAVNS)
Group C:none

Sponsors

The First Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patients undergoing elective radical resection of colorectal cancer under general anesthesia; ASA classification grades I to III; Voluntarily participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: Patients with the following conditions: Infection at the stimulation site or allergy to electrode pads; Mental abnormalities making it difficult to cooperate or communicate; Sensory disorders; Severe sinus bradycardia or presence of cardiac stents or pacemakers in the body.

Design outcomes

Primary

MeasureTime frame
Hemodynamic indices (heart rate, mean arterial pressure, cardiac output, cardiac index, stroke volume, and stroke volume variation);

Secondary

MeasureTime frame
The dosage of analgesic drugs during surgery;The occurrence of postoperative pulmonary complications within 7 days after surgery;The dosage of vasoactive drugs during surgery;Respiratory dynamics parameters;Inflammatory factor markers (serum levels of TNF-a and IL-1ß);Discharge time;Blood gas analysis results;

Countries

China

Contacts

Public ContactZhentao Sun

The First Affiliated Hospital of Zhengzhou University

gentlesun@126.com+86 136 0345 5483

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026